Geneos Wealth Management Inc. Alaunos Therapeutics, Inc. Transaction History

Geneos Wealth Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$0.41 - $1.24 $201 - $608	491 New	491 $0
Q3 2021 Nov 09, 2021	SELL	$1.44 - $2.73 $707 - $1,340	-491 Closed	0 $0
Q2 2021 Jul 08, 2021	SELL	$2.63 - $3.67 $5,210 - $7,270	-1,981 Reduced 80.14%	491 $1,000
Q2 2020 Sep 07, 2021	SELL	$2.2 - $3.71 $33 - $55	-15 Reduced 0.6%	2,472 $8,000
Q1 2018 Sep 07, 2021	BUY	$3.46 - $5.14 $51 - $77	15 Added 0.61%	2,487 $9,000
Q2 2017 Sep 07, 2021	BUY	N/A	481 Added 24.16%	2,472 $15,000
Q2 2016 Sep 07, 2021	SELL	N/A	-700 Reduced 26.01%	1,991 $11,000
Q1 2016 Sep 07, 2021	BUY	N/A	2,691	2,691 $20,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.